China SXT Pharmaceuticals... (SXTC)
NASDAQ: SXTC
· Real-Time Price · USD
1.60
0.02 (1.27%)
At close: Aug 15, 2025, 12:25 PM
China SXT Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 1.82M | 2.34M | 2.4M | 2.67M | 2.55M | 2.82M | 2.96M | -9.31M | -8.9M | -9.08M | -9.17M | -7M | -7.33M | -6.42M | -5.01M | 9.48M | 10M | 11.28M |
Cost of Revenue | 1.42M | 1.82M | 1.8M | 1.87M | 1.72M | 2.08M | 2.32M | 5.92M | 6.03M | 5.61M | 5.41M | 4.82M | 4.95M | 4.76M | 4.93M | 3.95M | 4.04M | 4.9M |
Gross Profit | 400.38K | 518.6K | 595.39K | 799.16K | 834.64K | 738.74K | 639.41K | -15.23M | -14.93M | -14.7M | -14.58M | -11.82M | -12.27M | -11.19M | -9.94M | 5.53M | 5.96M | 6.39M |
Operating Income | 6.2M | -2.83M | -7.19M | -15.06M | -20.53M | -12.34M | -8.24M | -2.5M | -1.6M | -3.34M | -4.21M | -3.07M | -3.6M | -125.75K | 1.9M | -7.48M | -6.36M | -7.17M |
Interest Income | n/a | n/a | 168.26K | 214.5K | 260.75K | 452.89K | 476.78K | 430.53K | 402.67K | 210.56K | 18.45K | 18.45K | 332.25K | 332.21K | 553.22K | 553.22K | 810.15K | 1.9M |
Pretax Income | 5.8M | -3.5M | -7.95M | -15.69M | -21.2M | -13M | -8.9M | -2.08M | -1.18M | -2.45M | -3.09M | -620.89K | -1.58M | 2M | 4.19M | -11.05M | -12.79M | -15.95M |
Net Income | 5.8M | -3.5M | -7.95M | -15.69M | -21.2M | -13M | -8.9M | -2.14M | -1.24M | -2.84M | -3.64M | -650.04K | -1.39M | 2.39M | 4.63M | -10.97M | -12.88M | -15.92M |
Selling & General & Admin | 7.76M | 16.91M | 21.34M | 22.64M | 21.37M | 13.07M | 8.88M | -4.36M | -4.97M | -2.99M | -2M | -4.73M | -4.66M | -7.35M | -8.13M | 12.71M | 12.01M | 13.55M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -13.56M | -13.56M | -13.56M | -6.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | -5.8M | 3.35M | 7.79M | 15.87M | 21.49M | 13.2M | 8.98M | -4.26M | -4.83M | -2.86M | -1.91M | -4.64M | -4.45M | -7.15M | -8.31M | 12.53M | 14.43M | 15.97M |
Interest Expense | n/a | n/a | n/a | 92.49K | 92.49K | 476.78K | 476.78K | 3.94M | 3.94M | 3.56M | 3.56M | 1.98M | 1.98M | 1.98M | 1.98M | n/a | n/a | n/a |
Selling & Marketing Expenses | 307.24K | 370.4K | 433.57K | 362.9K | 292.24K | 339.84K | 387.45K | -594.73K | -388.51K | -326.19K | -263.86K | -926.66K | -749.13K | -1.26M | -1.1M | 6.11M | 6.07M | 6.77M |
Cost & Expenses | -4.38M | 5.18M | 9.59M | 17.74M | 23.21M | 15.28M | 11.29M | 1.66M | 1.2M | 2.76M | 3.49M | 176.2K | 491.25K | -2.39M | -3.38M | 16.47M | 18.47M | 20.87M |
Income Tax Expense | n/a | n/a | n/a | 3.00 | 3.00 | 7.00 | 7.00 | -596.16K | -594.98K | -269.2K | -106.31K | 414.52K | 627.18K | 418.91K | 373.53K | 347.15K | 181.57K | 58.9K |
Shares Outstanding (Basic) | 403.92K | 403.92K | 1.23M | 867.42K | 501.47K | 501.47K | 431.63K | 431.63K | 102.32K | 102.32K | 52.08K | 52.08K | 31.1K | 31.1K | 28.78K | 28.78K | 28.78K | 28.78K |
Shares Outstanding (Diluted) | 403.92K | 403.92K | 1.23M | 867.42K | 501.47K | 501.47K | 431.63K | 431.63K | 102.32K | 102.32K | 52.08K | 52.08K | 31.1K | 31.1K | 28.78K | 28.78K | 28.78K | 28.78K |
EPS (Basic) | 3.36 | -5.32 | -14 | -21.81 | -29.62 | -27.25 | -24.88 | -45.13 | -65.38 | -107.79 | -150.2 | -196.54 | -242.88 | -169.17 | -95.46 | -320.77 | -546.08 | -673.4 |
EPS (Diluted) | 4.49 | -4.19 | -12.87 | -20.68 | -29.62 | -27.25 | -24.88 | -45.13 | -65.38 | -107.79 | -150.2 | -196.54 | -242.88 | -169.17 | -95.46 | -320.77 | -546.08 | -673.4 |
EBITDA | 6.79M | 2.45M | -1.89M | -7.55M | -13.21M | -9.11M | -5.01M | -4.11M | -3.2M | -4.04M | -4.87M | -5.39M | -5.9M | -3.89M | -1.87M | -728.63K | 409.54K | -335.91K |
EBIT | 6.62M | 2.26M | -2.09M | -7.77M | -13.46M | -9.36M | -5.26M | -4.35M | -3.45M | -4.32M | -5.19M | -5.72M | -6.25M | -4.22M | -2.2M | -1.08M | 43.45K | -648.84K |
Depreciation & Amortization | 169.04K | 237.52K | 254.62K | 344.57K | 364.42K | 371.63K | 375.24K | 369.05K | 365.96K | 441.99K | 480.01K | 508.49K | 522.73K | 519.66K | 518.12K | 553.93K | 571.83K | 522.45K |